Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tar 2.3% liquid
1305020C0AAFDFD
|
Coal tar/tar (Topical) | Tars | Skin | No data available |
|
Taranis low protein rusks
0913261V0BDAEAD
|
Taranis specialist food replacer sweet biscuits | Specialist food replacer sweet biscuits (0913261) | Nutrition and Blood | No data available |
|
Taranis low protein Snackybille cheese puff biscuits
0913451H0BBAAAA
|
Taranis food replacer discontinued or OTC savoury biscuits | Food replacer discontinued or OTC savoury biscuits (0913451) | Nutrition and Blood | No data available |
|
Tarceva 100mg tablets
0801050AEBBAAAA
|
Tarceva | Erlotinib | Malignant Disease and Immunosuppression | No data available |
|
Tarceva 150mg tablets
0801050AEBBABAB
|
Tarceva | Erlotinib | Malignant Disease and Immunosuppression | No data available |
|
Tarceva 25mg tablets
0801050AEBBACAC
|
Tarceva | Erlotinib | Malignant Disease and Immunosuppression | No data available |
|
Tardcaps XL 150mg capsules
0403040W0BFABAE
|
Tardcaps | Venlafaxine | Central Nervous System | No data available |
|
Tardcaps XL 75mg capsules
0403040W0BFAAAD
|
Tardcaps | Venlafaxine | Central Nervous System | No data available |
|
Tardiben 25mg tablets
0409030C0BFAAAA
|
Tardiben | Tetrabenazine | Central Nervous System | No data available |
|
Targocid 200mg inj vials
0501070T0BBABAB
|
Targocid | Teicoplanin | Infections | No data available |
|
Targocid 400mg inj vials
0501070T0BBAAAA
|
Targocid | Teicoplanin | Infections | No data available |
|
Targretin 75mg capsules
0801050ABBBAAAA
|
Targretin | Bexarotene | Malignant Disease and Immunosuppression | No data available |
|
Tarivid 200mg tablets
0501120P0BBAAAA
|
Tarivid | Ofloxacin | Infections | No data available |
|
Tarivid 200mg/100ml solution for infusion bottles
0501120P0BBADAC
|
Tarivid | Ofloxacin | Infections | No data available |
|
Tarivid 400mg tablets
0501120P0BBACAB
|
Tarivid | Ofloxacin | Infections | No data available |
|
Tarka modified-release capsules
0205051V0BBAAAA
|
Tarka | Trandolapril with calcium channel blocker | Cardiovascular System | No data available |
|
Tarodent 0.2% mouthwash
1203040E0BEAAAB
|
Tarodent | Chlorhexidine gluconate | Ear, Nose and Oropharynx | No data available |
|
Tartaric acid powder
190600000AAAZAZ
|
Generic compound preparation BNF 1906000 | Other acid preparations | Other Drugs and Preparations | No data available |
|
Tasigna 150mg capsules
0801050ASBBABAB
|
Tasigna | Nilotinib | Malignant Disease and Immunosuppression | No data available |
|
Tasigna 200mg capsules
0801050ASBBAAAA
|
Tasigna | Nilotinib | Malignant Disease and Immunosuppression | No data available |
|
Tasigna 50mg capsules
0801050ASBBACAC
|
Tasigna | Nilotinib | Malignant Disease and Immunosuppression | No data available |
|
Taurolidine 2% nebuliser liquid
0501070AAAAAAAA
|
Taurolidine | Taurolidine | Infections | No data available |
|
Taurolidine intraperitoneal solution bottles
0501070AAAAABAB
|
Taurolidine | Taurolidine | Infections | No data available |
|
Taurolin 100mg/5ml intraperitoneal solution bottles
0501070AABBAAAB
|
Taurolin | Taurolidine | Infections | No data available |
|
Tavanic 250mg tablets
0501120X0BBABAB
|
Tavanic | Levofloxacin | Infections | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.